APA (7th ed.) Citation

Henriksen, J. N., Andersen, C. U., Donskov, F., Hoffmann-Lücke, E., Greibe, E., & Fristrup, N. Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol. Medical Journals Sweden.

Chicago Style (17th ed.) Citation

Henriksen, Jakob N., Charlotte U. Andersen, Frede Donskov, Elke Hoffmann-Lücke, Eva Greibe, and Niels Fristrup. Therapeutic Drug Monitoring (TDM) of Tyrosine Kinase Inhibitors (TKI) for Optimized Outcome in Patients with Metastatic Renal Cell Carcinoma. The TKI-TDM Trial. Study Protocol. Medical Journals Sweden.

MLA (9th ed.) Citation

Henriksen, Jakob N., et al. Therapeutic Drug Monitoring (TDM) of Tyrosine Kinase Inhibitors (TKI) for Optimized Outcome in Patients with Metastatic Renal Cell Carcinoma. The TKI-TDM Trial. Study Protocol. Medical Journals Sweden.